Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, As Represented By”

2,152 pharma patents match "The United States of America, As Represented By" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,152
Index total 30,257
Page 26 / 90

Quick answer

This filtered view shows 2,152 pharmaceutical patents matching "The United States of America, As Represented By" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,152 results for “The United States of America, As Represented By” · 30,257 patents in full index Clear search

  1. US 10335423

    Inhibition of HIV infection through chemoprophylaxis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 2, 2019 · Expires Jun 27, 2039

    granted

  2. US 10335426

    N-acetyl mannosammine as a therapeutic agent

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 2, 2019 · Expires Jun 27, 2039

    granted

  3. US 10335478

    Avirulent, immunogenic flavivirus chimeras

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 2, 2019 · Expires Jun 27, 2039

    granted

  4. US 10329339

    Anti-human papillomavirus 16 E6 T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted

  5. US 10329259

    Pyrazole derivatives and their use as cannabinoid receptor mediators

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted

  6. US 10322146

    Methods of conditioning patients for T cell therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted

  7. US 10323083

    Agents that specifically bind matrilin-3 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted

  8. US 10316289

    Methods of producing T memory stem cell populations

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted

  9. US 10314900

    Lutzomyia longipalpis polypeptides and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted

  10. US 10314924

    RPGR gene therapy for retinitis pigmentosa

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted

  11. US 10308927

    Processing of a modified foot-and-mouth disease virus P1 polypeptide by an alternative protease

    The United States of America, as represented by the Secretary of Homeland Security · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  12. US 10307469

    Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  13. US 10308591

    Preparation of (R,R)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  14. US 10307476

    Genetically stable live attenuated respiratory syncytial virus vaccine and its production

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  15. US 10300115

    Methods and compositions for modulating immune tolerance

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 28, 2019 · Expires May 23, 2039

    granted

  16. US 10301314

    Compounds and methods for the prevention and treatment of tumor metastasis and tumorigenesis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 28, 2019 · Expires May 23, 2039

    granted

  17. US 10301621

    Multifunctional RNA nanoparticles and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 28, 2019 · Expires May 23, 2039

    granted

  18. US 10301377

    Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 28, 2019 · Expires May 23, 2039

    granted

  19. US 10293005

    Use of gram negative species to treat atopic dermatitis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 21, 2019 · Expires May 16, 2039

    granted

  20. US 10294483

    Eimeria tenella elongation factor-1 alpha recombinant immunogenic compositions which induce active protective immunity against avian coccidiosis

    The United States of America, as represented by the Secretary of Agriculture · Granted May 21, 2019 · Expires May 16, 2039

    granted

  21. US 10287297

    Epoxyazulene derivatives useful for treating cancer and diabetes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 14, 2019 · Expires May 9, 2039

    granted

  22. US 10287279

    Inhibitors of human 12/15-lipoxygenase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 14, 2019 · Expires May 9, 2039

    granted

  23. US 10287350

    Chimeric antigen receptors targeting CD-19

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 14, 2019 · Expires May 9, 2039

    granted

  24. US 10287340

    Anti-HIV domain antibodies and method of making and using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 14, 2019 · Expires May 9, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.